Lung Surfactant Decreases IL-1 and TNF-A Production at the Post-Transcriptional Level in LPS-Stimulated Alveolar Macrophages
Public Domain
-
2000/03/01
Details
-
Personal Author:
-
Description:We have shown previously that lung surfactant inhibits nitric oxide production at the post-transcriptional level in lipopolysaccharide(LPS)-stimulated rat alveolar macrophages (Miles et al., Am.J.Physiol. 276:Ll86, 1999). In this study, we examined the effect of lung surfactant (200 microg phospholipid/ml), isolated from rat lung lavage, on the production of two pro-inflammatory cytokines, IL-1B and TNF-a, by LPS-stimulated rat alveolar macrophages. After 22 h incubation with LPS plus lung surfactant, IL-1B and TNF-a production was reduced by 77% and 95%, respectively. mRNA levels were measured by Northern blot analysis, performed 4 hours after LPS-stimulation using digoxigenin-labeled probes. There was no difference in IL-1B or TNF-a mRNA levels between cells stimulated with LPS with or without lung surfactant. Nitric oxide, IL-1B and TNF-a are known to be regulated at both the transcriptional and post-transcriptional levels. It is interesting that lung surfactant inhibits the production of all three pro-inflammatory molecules at the post-transcriptional level. This suggests that the post-transcriptional regulation of these three molecules may share a similar mechanism. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1082-5589
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:48
-
Issue:2
-
NIOSHTIC Number:nn:20032619
-
Citation:J Investig Med 2000 Mar; 48(2):200A
-
CAS Registry Number:
-
Federal Fiscal Year:2000
-
Peer Reviewed:False
-
Source Full Name:Journal of Investigative Medicine
-
Collection(s):
-
Main Document Checksum:urn:sha-512:c71ad64df9b416a97d62e8686cffe3cb5d9afe6009f6a7a38e9c17d356325777e3b604370cd68dd64ffb7ff5a51ed0e0473149c20b8cbcbca13b537ffd0b96ab
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like